Category: Politics and Regulation

Missouri tackles primary care shortage with “assistant physicians”

A new law in Missouri will allow medical school graduates who have not completed a residency to practice in underserved areas. They will be able to call themselves “doctor” but will be licensed as “assistant physicians” with significant limitations on their practice. (The first link is to Senate Bill 716, the bill that was passed and signed by the governor. It covers...

/ September 18, 2014

Legislating Ignorance

Science is under attack, and not just from anti-vaccine celebrities and parents with degrees from Google University. Scientific illiteracy is being woven into the very fabric of our society through legislative assault. If you dismiss this as alarmist hyperbole, you haven’t been paying close enough attention. Every day thousands of pediatric health care providers throughout the country provide safety advice to patients...

/ September 12, 2014

Tens of millions for CAM research — and it’s all on your dime

The Federal Funding Accountability and Transparency Act (FFATA) was signed on September 26, 2006. The intent is to empower every American with the ability to hold the government accountable for each spending decision. The end result is to reduce wasteful spending in the government. The FFATA legislation requires information on federal awards (federal financial assistance and expenditures) be made available to the...

/ August 21, 2014

Medical marijuana as the new herbalism, part 2: Cannabis does not cure cancer

Medical marijuana. It’s promoted as a seeming panacea that can cure whatever ails you. In particular, it's touted, primarily in the form of cannabis oil extract, as a cure for cancer that "they" don't want you to know about. While there are potentially useful medicinal compounds in marijuana, in general the medical marijuana movement vastly oversells the promise. While some cannabinoids do...

/ August 11, 2014

Chiropractic scope of practice includes . . . well, you won’t believe it

Ladies, how would you like a chiropractor to deliver your baby? How about perform your annual well-woman exams, such as breast exam, bi-manual pelvic exam, speculum exam, recto-vaginal exam and Pap smear? Sound out of their league? I thought so too. Way out. But, in some parts of the U.S., the law allows chiropractors to do all of these things and a...

/ August 7, 2014
Right-to-try

The false hope of “right-to-try” metastasizes to Michigan

State "right-to-try" bills are springing up like kudzu all over the US. Their advocates promise that they will save lives by allowing terminally ill patients access to experimental therapeutics, when in fact they are highly unlikely to do any such thing given that the federal government, not the states, controls drug approval. In reality, right-to-try laws are a cruel sham that will...

/ July 21, 2014

The Texas Medical Board vs. Stanislaw Burzynski, 2014 edition

Here we go again. I'll give the Texas Medical Board credit for one thing. It's persistent. It's going after Stanislaw Burzynski's medical license again. Will this finally be the time the TMB puts a stop to Burzynski's abuse of the clinical trial process and patients? Or will this be a replay of the 1990s, with Burzynski slithering away yet again?

/ July 14, 2014

Medical marijuana as the new herbalism, part 1: Science versus the politics of weed in New York and beyond

Medical marijuana. It's promoted as a seeming panacea that can cure whatever ails you. While there are potentially useful medicinal compounds in marijuana, in general the medical marijuana movement vastly oversells the promise. The truth is far more prosaic and nuanced.

/ July 7, 2014

The Center for Inquiry weighs in on the FDA’s mishandling of Stanislaw Burzynski’s clinical trials

The Center for Inquiry points out how what Stanislaw Burzynski is doing corrupts the clinical trial process and harms patients.

/ July 3, 2014

Stanislaw Burzynski’s propaganda victory on antineoplastons: The FDA really caves

Once more, the FDA fails to shut down Stanislaw Burzynski's clinic and antineoplaston manufacturing operation. Cancer patients will suffer as a result of the FDA's failure.

/ July 1, 2014